C12N 2710/10352
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2710/10352 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 127 US grants and 168 published applications in this corpus.
Search patents in C12N- Granted patents
- 127
- Published applications
- 168
- Assignees
- 85
- Inventors
- 259
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 4 |
| 2002 | 9 | 18 |
| 2003 | 8 | 20 |
| 2004 | 5 | 5 |
| 2005 | 9 | 13 |
| 2006 | 12 | 8 |
| 2007 | 5 | 6 |
| 2008 | 3 | 7 |
| 2009 | 5 | 5 |
| 2010 | 4 | 5 |
| 2011 | 1 | 5 |
| 2012 | 5 | 2 |
| 2013 | 0 | 3 |
| 2014 | 2 | 2 |
| 2015 | 4 | 5 |
| 2016 | 3 | 3 |
| 2017 | 4 | 2 |
| 2018 | 0 | 5 |
| 2019 | 2 | 3 |
| 2020 | 3 | 9 |
| 2021 | 1 | 5 |
| 2022 | 3 | 9 |
| 2023 | 6 | 12 |
| 2024 | 3 | 5 |
| 2025 | 8 | 6 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Rescue of recombinant adenoviruses by CRISPR/Cas-mediated in vivo terminal resolution25 Aug 2026US 12,716,064 B2Albert-Ludwigs-Universität Freiburg
- Recombinant adenovirus expressing African swine fever virus EP153R-EP402R protein and construction method thereof5 May 2026US 12,618,083 B2Institute of Animal Sciences of Chinese Academy of Agricultural Sciences
- Single plasmid vector system for packaging recombinant human adenovirus type 4 and application thereof4 Nov 2025US 12,460,227 B2Academy of Military Medical Science, PLA
- Adenoviral vectors comprising partial deletions of E319 Aug 2025US 12,391,959 B2The Wistar Institute
- Fast and accurate three-plasmid oncolytic adenovirus recombinant packaging system Ad5MixPlus and application thereof29 Jul 2025US 12,371,670 B2Voncolytic Therapeutics Co., Ltd.
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Adenoviral helper vectors4 Dec 2025US 2025/0369013 A1Ensoma, Inc.
- Adenoviral Vectors Comprising Partial Deletions of E320 Nov 2025US 2025/0354172 A1The Wistar Institute
- Rescue of recombinant adenoviruses by crispr/cas-mediated in vivo terminal resolution28 Aug 2025US 2025/0270545 A1Albert-Ludwigs-Universität Freiburg
- Modified adenoviruses24 Jul 2025US 2025/0236884 A1Gritstone Bio, Inc.
Most cited
By later US patents
- Packaging systems for human recombinant adenovirus to be used in gene therapy267US 5,994,128 AIntrogene B.V. · 1999
- Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus184US 5,994,106 AGenVec, Inc. · 1999
- Packaging systems for human recombinant adenovirus to be used in gene therapy178US 6,033,908 AIntrogene B.V. · 2000
- Complementary adenoviral systems and cell lines125US 5,851,806 AGenVec, Inc. · 1998
- Defective adenoviruses and corresponding complementation lines113US 6,040,174 ATransgene S. A. · 2000